ALPINE GROUP PARTNERS, LLC. for CARL ZEISS, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Science/Technology SCI
Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care
Foreign entity interest: As indicated in the registration, company is headquartered in Germany
| Lobbyist | Covered position, as disclosed |
|---|---|
| COLIN BRAINARD | — |
| MICHAEL SEAN HAYWOOD | — |
| ERIN MENDELSOHN | — |
| CURTIS PHILIP | — |
| RHOD SHAW | — |
Trade (domestic/foreign) TRD
Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care
Foreign entity interest: As indicated in the registration, company is headquartered in Germany
| Lobbyist | Covered position, as disclosed |
|---|---|
| COLIN BRAINARD | — |
| MICHAEL SEAN HAYWOOD | — |
| ERIN MENDELSOHN | — |
| CURTIS PHILIP | — |
| RHOD SHAW | — |
Manufacturing MAN
Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care
Foreign entity interest: As indicated in the registration, company is headquartered in Germany
| Lobbyist | Covered position, as disclosed |
|---|---|
| COLIN BRAINARD | — |
| MICHAEL SEAN HAYWOOD | — |
| ERIN MENDELSOHN | — |
| CURTIS PHILIP | — |
| RHOD SHAW | — |
Waste (hazardous/solid/interstate/nuclear) WAS
Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care
Foreign entity interest: As indicated in the registration, company is headquartered in Germany
| Lobbyist | Covered position, as disclosed |
|---|---|
| COLIN BRAINARD | — |
| MICHAEL SEAN HAYWOOD | — |
| ERIN MENDELSOHN | — |
| CURTIS PHILIP | — |
| RHOD SHAW | — |
Health Issues HCR
Medical Technology, funding opportunities for biomedical research and export control policies; US Export Control Policy; Trade and tariff policy; Medical and IndustrialQuality & Research; Metrology/Microscopy Technology; PFAS regulations; Medical Technology, federal funding opportunities for biomedical research, MDUFA and vision care
Foreign entity interest: As indicated in the registration, company is headquartered in Germany
| Lobbyist | Covered position, as disclosed |
|---|---|
| COLIN BRAINARD | — |
| MICHAEL SEAN HAYWOOD | — |
| ERIN MENDELSOHN | — |
| CURTIS PHILIP | — |
| RHOD SHAW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.